Switch to:
More From Other Websites
Novartis launches first U.S. 'biosimilar' drug at 15 pct discount Sep 03 2015
Novartis launches first U.S. 'biosimilar' drug at 15 pct discount Sep 03 2015
Novartis launches first biological copycat drug in US Sep 03 2015
Bristol-Myers/AbbVie Cancer Drug Gets Priority Review Sep 02 2015
9:29 am AbbVie: Par Pharmaceutical begins shipping testosterone gel 1%, the generic version of... Sep 02 2015
The End Of Humira’s Patent - Is AbbVie Prepared? Sep 01 2015
U.S. Food and Drug Administration Accepts for Priority Review the Biologics License Application for... Sep 01 2015
Short Sellers Have Mixed Feelings on Major Pharma Aug 26 2015
Medivation Buying Breast-Cancer Drug From BioMarin Aug 24 2015
AbbVie or Baxalta: Which Is the Better Biopharma Investment Today? Aug 21 2015
Billionaire Larry Robbins Has Healthy Stakes In Health Stocks Aug 20 2015
AbbVie Pays $350 Mil For United Therapeutics Voucher Aug 19 2015
AbbVie buys special review voucher for $350 mln Aug 19 2015
Hedge Funds Are Pouring Money Into These Stocks Aug 19 2015
Biotech Stock Roundup: Kite Addresses Patient Death Concerns, Omeros Soars on Data Aug 19 2015
United Therapeutics Sells Priority-Review Voucher to AbbVie Aug 19 2015
United Therapeutics Corporation Agrees to Sell Priority Review Voucher to AbbVie for $350 Million Aug 19 2015
United Therapeutics Corporation Agrees to Sell Priority Review Voucher to AbbVie for $350 Million Aug 19 2015


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK